Adult Stem Cells Market
Adult Stem Cells Market - Global Industry Assessment & Forecast
Segments Covered
- By Type Epithelial Stem Cells, Hematopoietic Stem Cells
- By Application Therapeutics,, Disease Modeling,, Drug Development & Discovery,, Toxicology Studies,, Biobanking,, Tissue Engineering,, Others
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2024 |
Forecast Years: | 2025 - 2034 |
Historical Years: | 2019 - 2023 |
Revenue 2024: | USD 9.24 Billion |
Revenue 2034: | USD 23.96 Billion |
Revenue CAGR (2025 - 2034): | 10.0% |
Fastest Growing Region (2025 - 2034) | XX |
Largest Region (2024): | XX |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Key Insights
The Global Adult Stem Cells Market is valued at USD 9.24 Billion in 2024 and is projected to reach a value of USD 23.96 Billion by 2034 at a CAGR (Compound Annual Growth Rate) of 10.0% between 2025 and 2034.
Definition and Overview
Adult Stem Cells are undifferentiated cells, found throughout the body after development, that multiply by cell division to replenish dying cells and regenerate damaged tissues. Also known as somatic stem cells (from Greek σωματικóς, meaning of the body), they can be found in juvenile, adult animals, and humans, unlike embryonic stem cells.
The global Adult Stem Cells market report provides exhaustive analysis on segments, regions/countries, companies, and such several strategic marketing tools such as Porter’s Five Forces Analysis, Pricing Analysis, SWOT Analysis, PESTLE Analysis, Player Positioning Analysis, Downstream Buyers, List of distributors, and Value Chain Analysis among others. The report covers market size and estimations for each segment/region/country for the years 2023–2034. It provides a detailed study on various product types and their applications in different industry verticals at the global/regional/country level. Moreover, the report includes a thorough analysis on competitive landscape comprising of extensive company profiles based on various parameters such as company overview, market revenue, business, product portfolio, and marketing strategies among others.
Adult Stem Cells Market Size, 2024 To 2034 (USD Billion)
AI (GPT) is here !!! Ask questions about Adult Stem Cells Market
COVID-19 Impact Analysis
Outbreak of COVID-19 in 2020 compelled governments across the world to take severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to restrict swift spread of COVID-19. However, these actions had a drastic impact on the global economy, as the companies across the globe were forced to either close or partially closed their operations, leading to supply chain disruptions and impairing of various industries. Moreover, in 2024 several key markets such as U.S, India, and Brazil among other witnessed second wave of COVID-19 that further disrupted the market. However, it is expected that reopening of trade activities, the market will witness steady growth in demand in the coming years. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.
The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:
- Impact Assessment of COVID-19 Pandemic
- Pre & Post COVID-19 Market Size
- Qualitative analysis on the short term & long-term impact of COVID-19 on the market
- The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.
Market Segmentation
The report delivers an acute breakdown of the market based on various segments such as Type, Application and region. This study comprises the market size in terms of revenue for each segment at the global/regional/country level along with a detailed analysis of growth prospects, challenges, and opportunities.
On the basis of Type, the market is divided into Epithelial Stem Cells, Hematopoietic Stem Cells. Epithelial Stem Cells is expected to dominate the market and is projected to grow at a noteworthy CAGR within the forecast period.
Based on Application, the market is divided into Neurodegenerative Diseases, Heart Diseases, Bone Diseases, Others. Neurodegenerative Diseases attributed to the highest market share and is expected to grow at a significant CAGR from 2025 to 2034.
Report Coverage & Deliverables
Get Access Now
Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point
Regional Analysis: Preview
Geographically, the global Adult Stem Cells market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. The report further segments the regional study into key country-level markets from each region. The regional analysis section provides extensive analysis on various factors impacting market growth such as economies, industry competition, technological advancements, import-export ratio, and raw material availability among others. Moreover, the same section will provide your detailed qualitative as well as quantitative analysis for each region country comprising of market size and estimations for each region/country. Some of the prominent country-level markets are U.S, China, Germany, France, India, and Japan. North America is anticipated to dominate the global market during upcoming years.
Competitive Landscape
Major players in the global Adult Stem Cells market are Intellicell Biosciences Inc., Globalstem, Neurogeneration, Capricor Inc., Caladrius Biosciences Inc., Mesoblast Ltd., Celyad, Juventas Therapeutics Inc., Cytori Therapeutics Inc., Cellular Dynamics International, Epistem Ltd., Brainstorm Cell Therapeutics Inc., Cellerant Therapeutics Inc., Hybrid Organ Gmbh, Cellerix Sa.. The global Adult Stem Cells market report analyzes competitive scenario in detail that includes extensive information on all key players based on business overview, product portfolio, marketing strategies, recent developments, financial performance, and geographical presence among others. In addition to that, the report also covers company market share for the year 2022 along with in depth strategic developments.
The global Adult Stem Cells market can be categorized as Type, Application, End-Use Industry, and Region.
Parameter | Details |
---|---|
Segments Covered |
By Type
By Application
By Region
|
Regions & Countries Covered |
|
Companies Covered |
|
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis |
Pricing and purchase options | Avail of customized purchase options to meet your exact research needs. Explore purchase options |
FAQ
Frequently Asked Question
What is the global demand for Adult Stem Cells in terms of revenue?
-
The global Adult Stem Cells valued at USD 9.24 Billion in 2024 and is expected to reach USD 23.96 Billion in 2034 growing at a CAGR of 10.0%.
Which are the prominent players in the market?
-
The prominent players in the market are Intellicell Biosciences Inc., Globalstem, Neurogeneration, Capricor Inc., Caladrius Biosciences Inc., Mesoblast Ltd., Celyad, Juventas Therapeutics Inc., Cytori Therapeutics Inc., Cellular Dynamics International, Epistem Ltd., Brainstorm Cell Therapeutics Inc., Cellerant Therapeutics Inc., Hybrid Organ Gmbh, Cellerix Sa..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 10.0% between 2025 and 2034.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Adult Stem Cells include
Which region accounted for the largest share in the market?
-
XX was the leading regional segment of the Adult Stem Cells in 2024.